WOCKHARDT
Back to Balance Sheet
|
WOCKHARDT Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹643 Cr | ₹882 Cr | ₹866 Cr | ₹840 Cr | ₹639 Cr |
What is the latest Contingent Liabilities ratio of WOCKHARDT ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹643 Cr |
| Mar2024 | ₹882 Cr |
| Mar2023 | ₹866 Cr |
| Mar2022 | ₹840 Cr |
| Mar2021 | ₹639 Cr |
How is Contingent Liabilities of WOCKHARDT Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹643 Cr | -27.11 | |
| Mar2024 | ₹882 Cr | 1.87 | |
| Mar2023 | ₹866 Cr | 3.13 | |
| Mar2022 | ₹840 Cr | 31.46 | |
| Mar2021 | ₹639 Cr | - | |
Compare Contingent Liabilities of peers of WOCKHARDT
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WOCKHARDT | ₹31,672.1 Cr | -3.2% | 10% | 13.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,299.0 Cr | 0.5% | 1.5% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,207.0 Cr | -3.3% | -3.5% | 1.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,721.0 Cr | 4.5% | 2.6% | 42.6% | Stock Analytics | |
| CIPLA | ₹117,420.0 Cr | 2.7% | 2.5% | -4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,876.0 Cr | 6.6% | 4.3% | 1.9% | Stock Analytics | |
WOCKHARDT Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WOCKHARDT | -3.2% |
10% |
13.5% |
| SENSEX | -0.1% |
1% |
-5.7% |
You may also like the below Video Courses